Cointime

CellSeed

company

About

CellSeed develops regenerative medicine products primarily in Japan and Europe.

  • 11 - 50

Highlights

Total Funding Amount
¥818M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥818M
Industries
Alternative Medicine,Health Care,Market Research
Founded date
May 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment of osteoarthritis

The company was founded in 2001 and is headquartered in Tokyo, Japan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥818M
CellSeed has raised a total of ¥818M in funding over 2 rounds. Their latest funding was raised on Nov 2, 2005 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 2, 2005 Series Unknown ¥818M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
CellSeed is funded by 1 investors. Nissei Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Nissei Capital — Series Unknown
Cointime
Содержание
компания